Previous 10 | Next 10 |
NOVATO, Calif. and SAN DIEGO, May 21, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical, Inc. (Nasdaq: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases and Arcturus Therapeutics Holdings I...
Sorrento Therapeutics (NASDAQ: SRNE ) +36% in reaction to reports that it has discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc., Moderna, Inc., Fulgent Genetics, Inc., Stocks on the ...
The entire world anxiously awaits good news in the race to develop a vaccine for novel coronavirus disease COVID-19 . And there are plenty of drugmakers hoping to be the bearers of some good news, including both big pharmaceutical companies and small biotechs. Some investors could be temp...
Investors are warming to the smaller COVID-19 vaccine developers at the apparent expense of the traditional "big four" of Sanofi ( SNY -1.5% ), J&J ( JNJ -0.3% ), GlaxoSmithKline ( GSK -0.3% ) and Pfizer ( PFE -0.6% ). More news on: Sanofi, Johnson & Johnson, GlaxoSmithKlin...
Eli Lilly Receives FDA Endorsement for Retevmo Eli Lilly and Company (LLY) announced that the FDA has granted its approval for Retevmo, making it the first approved therapy specifically targeting adult patients with metastatic rearranged during transfection ((RET)) fusion-positive non-smal...
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Neda Safarzadeh – Head-Investor Relations Joseph Payne – president and Chief Executive Officer Andy Sassine – Chief Financial Officer Pad...
Image source: The Motley Fool. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Q1 2020 Earnings Call May 07, 2020 , 4:30 p.m. ET Operator Continue reading
The need for capital continues apace for healthcare companies as they deal with COVID-19 disruptions. More news on: Check-Cap Ltd., Cellectar Biosciences, Inc., BioTelemetry, Inc., Healthcare stocks news, , Read more ...
The following healthcare companies have recently filed for mixed shelf offerings: More news on: Clearside Biomedical, Inc., Mersana Therapeutics, Inc., Arcturus Therapeutics Holdings Inc., Healthcare stocks news, , Read more ...
Arcturus Therapeutics Holdings ( ARCT +6.1% ) perks up, albeit on below-average volume, on the heels of new preclinical data supporting its COVID-10 vaccine program LUNAR-COV19. More news on: Arcturus Therapeutics Holdings Inc., Healthcare stocks news, Stocks on the move, Read more...
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
NASDAQ Market:
Arcturus Therapeutics Ltd. Website:
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, toda...
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...